PC5 Stock Overview
Plant Health Care plc, together with its subsidiaries, provides agricultural biological products and technology solutions in the Americas, Mexico, and internationally.
| Snowflake Score | |
|---|---|
| Valuation | 2/6 |
| Future Growth | 2/6 |
| Past Performance | 0/6 |
| Financial Health | 3/6 |
| Dividends | 0/6 |
Rewards
Risk Analysis
+ 1 more risk
Plant Health Care plc Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | UK£0.032 |
| 52 Week High | UK£0.12 |
| 52 Week Low | UK£0.028 |
| Beta | 0.75 |
| 1 Month Change | 12.28% |
| 3 Month Change | -4.48% |
| 1 Year Change | -68.93% |
| 3 Year Change | -79.87% |
| 5 Year Change | -52.94% |
| Change since IPO | -80.12% |
Recent News & Updates
Recent updates
Shareholder Returns
| PC5 | DE Chemicals | DE Market | |
|---|---|---|---|
| 7D | 0% | -1.6% | 0.5% |
| 1Y | -68.9% | 0.9% | 1.3% |
Return vs Industry: PC5 underperformed the German Chemicals industry which returned -0.3% over the past year.
Return vs Market: PC5 underperformed the German Market which returned 2.3% over the past year.
Price Volatility
| PC5 volatility | |
|---|---|
| PC5 Average Weekly Movement | 8.5% |
| Chemicals Industry Average Movement | 4.1% |
| Market Average Movement | 4.8% |
| 10% most volatile stocks in DE Market | 10.2% |
| 10% least volatile stocks in DE Market | 2.4% |
Stable Share Price: PC5 has not had significant price volatility in the past 3 months.
Volatility Over Time: PC5's weekly volatility (9%) has been stable over the past year, but is still higher than 75% of German stocks.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1995 | 56 | Jeff Tweedy | www.planthealthcare.com |
Plant Health Care plc, together with its subsidiaries, provides agricultural biological products and technology solutions in the Americas, Mexico, and internationally. It offers products to enhance the yield and quality of crops, such as corn, soybeans, sugar cane, citrus, and rice, as well as fruits and vegetables. The company provides Harpin aß, a recombinant protein, which acts as a biostimulant to enhance the yield and quality of crops; and Saori, a vaccine for plants that promotes healthy growth of soybeans and helps them fight disease.
Plant Health Care plc Fundamentals Summary
| PC5 fundamental statistics | |
|---|---|
| Market cap | €15.18m |
| Earnings (TTM) | -€5.35m |
| Revenue (TTM) | €11.01m |
1.4x
P/S Ratio-2.8x
P/E RatioIs PC5 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| PC5 income statement (TTM) | |
|---|---|
| Revenue | US$11.82m |
| Cost of Revenue | US$4.67m |
| Gross Profit | US$7.15m |
| Other Expenses | US$12.88m |
| Earnings | -US$5.73m |
Last Reported Earnings
Jun 30, 2023
Next Earnings Date
n/a
| Earnings per share (EPS) | -0.017 |
| Gross Margin | 60.48% |
| Net Profit Margin | -48.53% |
| Debt/Equity Ratio | 3.2% |
How did PC5 perform over the long term?
See historical performance and comparison